| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |